|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.56 USD | -4.81% |
|
-23.00% | -19.61% |
| 05:55am | GeneDx Holdings Corp. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 03:00 PM | |
| 12/01 | Genedx shares down 2.5% after announcing preliminary Q4 results, 2026 outlook | RE |
| Capitalization | 302.23Cr 259.34Cr 241.47Cr 224.71Cr 419.32Cr 27TCr 452.04Cr 2.78TCr 1.09TCr 13TCr 1.13TCr 1.11TCr 48TCr | P/E ratio 2025 * |
-158x | P/E ratio 2026 * | -57.3x |
|---|---|---|---|---|---|
| Enterprise value | 302.23Cr 259.34Cr 241.47Cr 224.71Cr 419.32Cr 27TCr 452.04Cr 2.78TCr 1.09TCr 13TCr 1.13TCr 1.11TCr 48TCr | EV / Sales 2025 * |
7.08x | EV / Sales 2026 * | 5.61x |
| Free-Float |
81.87% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: GeneDx Holdings Corp.
More recommendations
More press releases
| 1 day | -4.81% | ||
| 1 week | -23.00% | ||
| Current month | -19.61% | ||
| 1 month | -30.99% | ||
| 3 months | -13.49% | ||
| 6 months | +26.65% | ||
| Current year | -19.61% |
| 1 week | 103.94 |  | 140.83 |
| 1 month | 103.94 | | 156.93 |
| Current year | 103.94 | | 140.83 |
| 1 year | 55.17 | | 170.87 |
| 3 years | 1.16 | | 170.87 |
| 5 years | 1.16 | | 896.94 |
| 10 years | 1.16 | | 896.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 29/04/2022 | |
Kevin Feeley
DFI | Director of Finance/CFO | 45 | 26/08/2022 |
Linda Genen
CTO | Chief Tech/Sci/R&D Officer | - | 06/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Joshua Ruch
BRD | Director/Board Member | 76 | 22/07/2021 |
Eli Casdin
BRD | Director/Board Member | 53 | 01/07/2020 |
Emily Leproust
BRD | Director/Board Member | 53 | 01/09/2020 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.26% | 0% | 293,477 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.81% | -23.00% | +23.00% | +577.03% | 317.49Cr | |
| +0.55% | -3.84% | +41.28% | +471.95% | 3.29TCr | |
| +0.67% | +5.28% | -16.48% | -25.48% | 759.78Cr | |
| -1.67% | -5.77% | +9.48% | +264.50% | 572.97Cr | |
| -0.76% | -4.67% | -1.52% | +29.84% | 262.92Cr | |
| +1.17% | +67.90% | +184.20% | +11.53% | 255.44Cr | |
| +0.85% | +21.92% | +45.40% | -55.49% | 243.58Cr | |
| 0.00% | -8.77% | - | - | 171.85Cr | |
| +2.24% | +3.28% | +4.67% | +20.40% | 167.3Cr | |
| +5.35% | -0.19% | +34.72% | +7.63% | 152.97Cr | |
| Average | +0.36% | +4.88% | +36.08% | +144.66% | 619.48Cr | |
| Weighted average by Cap. | +0.21% | -1.12% | +33.18% | +310.51% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 43Cr 37Cr 34Cr 32Cr 59Cr 3.86TCr 64Cr 392.27Cr 154.32Cr 1.84TCr 160.16Cr 156.86Cr 6.76TCr | 54Cr 46Cr 43Cr 40Cr 75Cr 4.86TCr 81Cr 494.74Cr 194.63Cr 2.33TCr 202Cr 197.83Cr 8.52TCr |
| Net income | -2.02Cr -1.73Cr -1.61Cr -1.5Cr -2.8Cr -182.06Cr -3.02Cr -19Cr -7.29Cr -87Cr -7.56Cr -7.41Cr -319.12Cr | -5.78Cr -4.96Cr -4.62Cr -4.3Cr -8.02Cr -521.79Cr -8.65Cr -53Cr -21Cr -249.61Cr -22Cr -21Cr -914.62Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,000
Calendar
15/01/2026
- J.P. Morgan Healthcare Conference
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | 104.50 $ | -4.86% | 7,18,750 |
| 13/26/13 | 109.84 $ | -7.88% | 9,04,200 |
| 12/26/12 | 119.24 $ | -11.92% | 21,47,719 |
| 09/26/09 | 135.38 $ | -1.52% | 4,64,375 |
| 08/26/08 | 137.47 $ | +0.67% | 2,95,929 |
Delayed Quote Nasdaq, January 15, 2026 at 02:30 am IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
104.50USD
Average target price
170.89USD
Spread / Average Target
+63.52%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WGS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition